Zealand Pharma A/S
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Zealand Pharma A/S
Zealand Pharma AS is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The company has out-licensed a peptide program to Boehringer Ingelheim that has been moved ahead into early clinical development: a once-weekly novel dual-acting GLP-1/glucagon agonist for the treatment of obesity and/or Type 2 diabetes.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Zealand Pharma A/S stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Zealand Pharma A/S by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Zealand Pharma A/S is ZEAL:xcse. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Zealand Pharma A/S has its primary listing on NASDAQ OMX Copenhagen. You can trade Zealand Pharma A/S with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Zealand Pharma A/S is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Zealand Pharma A/S as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Zealand Pharma A/S.